Curtis Gale Oltmans serves as Executive at ARRAY BIOPHARMA INC, where they oversee executive responsibilities. Since joining the company, Curtis Gale Oltmans has executed 15 insider transactions totaling $1.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved selling 3,452 shares valued at $44.6K.
Curtis Gale Oltmans currently holds 10,252 shares of ARRAY BIOPHARMA INC (ARRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Curtis Gale Oltmans has been a net seller of ARRY stock. They have purchased $9.8K and sold $1.5M worth of shares.
Curtis Gale Oltmans's most recent insider trade was on Dec 15, 2025, when they sold 3,452 shares at $12.92 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 17, 2021 | ATXI | $0 | Award | 49,020 | $N/A | Discretionary |
| Jun 28, 2021 | FULC | $9.8K | Purchase | 1,088 | $9.01 | Discretionary |
| Feb 5, 2019 | ARRY | $357.6K | Option Exercise | 40,000 | $8.94 | Discretionary |
| Feb 5, 2019 | ARRY | $800.0K | Sale | 40,000 | $20.00 | Discretionary |
| Jan 29, 2019 | ARRY | $99.2K | Option Exercise | 11,100 | $8.94 | Discretionary |
| Jan 25, 2019 | ARRY | $252.5K | Sale | 14,029 | $18.00 | Discretionary |
| Jan 25, 2019 | ARRY | $125.4K | Option Exercise | 14,029 | $8.94 | Discretionary |
| Jan 18, 2019 | ARRY | $22.5K | Sale | 1,251 | $18.00 | Discretionary |
| Jan 18, 2019 | ARRY | $11.2K | Option Exercise | 1,251 | $8.94 | Discretionary |
| Jan 15, 2019 | ARRY | $356.1K | Sale | 19,720 | $18.06 | Discretionary |
| Jan 15, 2019 | ARRY | $176.3K | Option Exercise | 19,720 | $8.94 | Discretionary |
| Dec 16, 2018 | ARRY | $49.2K | Payment | 3,079 | $15.97 | Discretionary |
| Dec 16, 2018 | ARRY | $0 | Option Exercise | 7,000 | $N/A | Discretionary |